Tags:CareDiagnosticsHealthTechMedtechNewsPersonalScienceServiceTechnology
Genoptix, a NeoGenomics Company Right Answer, Right Now Advancing positive outcomes in oncology through innovation, quality and service Oncology Expertise For almost 20 years, Genoptix, a NeoGenomics Company, has provided the vital insights cancer care teams need to achieve the best possible outcome for each and every patient. Our broad menu of testing solutions spans from pathology expertise to next-generation testing, enabling confident decisions in optimizing precision medicine. Having diagnosed over 1.7 million patients and counting, Genoptix sets a higher standard of quality, from science to service. Because what matters most is delivering the right answer, right now. For more details, see http://www.genoptix.com. For the latest news, visit NeoGenomics Laboratories at https://www.linkedin.com/company/neogenomics-laboratories.
Location: United States, California, Carlsbad
Member count: 201-500
Total raised: $17.3M
Founded date: 1999

Investors 3

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
09.08.2005Series D$17.3M--

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
03.12.2020Slone Part...“John Leite is an experienced ...--prweb.com/...
30.10.2018Term Sheet...CRYPTO FUNDING Good morning, ...--fortune.co...
08.03.2017Term Sheet...HEAVY LIFTING Good morning! I...--fortune.co...
07.03.2017Ampersand ...The management team led by Jos...USA-finsmes.co...
30.01.2017Term Sheet...THE WEEKEND The tech industry...--fortune.co...
30.10.2007Life scien...Featured companies: Acceleron ...--venturebea...
01.08.2007Genoptix f...Genoptix, a Carlsbad, Calif., ...--venturebea...